Ipilimumab/Nivolumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of ipilimumab and nivolumab that can be used for the treatment of bone, cervical, kidney, colorectal, esophageal and esophagogastric junction, head and neck, hepatocellular, biliary tract, ovarian, fallopian tube, primary peritoneal, vulvar, and vaginal cancers, melanoma, non-small cell lung cancer (NSCLC), malignant pleural/peritoneal mesothelioma, soft tissue sarcoma, gastrointestinal stromal tumor (GIST), uterine sarcoma, pancreatic adenocarcinoma, Kaposi sarcoma, angiosarcoma, Merkel cell carcinoma, and adrenal gland tumors.

**Synonyms:** - Ipilimumab + Nivolumab - Ipilimumab Plus Nivolumab - Ipilimumab and Nivolumab - Ipilimumab-Nivolumab - Ipilimumab-Nivolumab Regimen - Ipilimumab/Nivolumab - Nivolumab/Ipilimumab